298 related articles for article (PubMed ID: 1549234)
1. Heterozygote ornithine transcarbamylase deficiency presenting as symptomatic hyperammonemia during initiation of valproate therapy.
Honeycutt D; Callahan K; Rutledge L; Evans B
Neurology; 1992 Mar; 42(3 Pt 1):666-8. PubMed ID: 1549234
[TBL] [Abstract][Full Text] [Related]
2. Valproate as a cause of hyperammonemia in heterozygotes with ornithine-transcarbamylase deficiency.
Leão M
Neurology; 1995 Mar; 45(3 Pt 1):593-4. PubMed ID: 7898728
[No Abstract] [Full Text] [Related]
3. Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamylase deficiency.
Oechsner M; Steen C; Stürenburg HJ; Kohlschütter A
J Neurol Neurosurg Psychiatry; 1998 May; 64(5):680-2. PubMed ID: 9598692
[TBL] [Abstract][Full Text] [Related]
4. Ornithine transcarbamylase deficiency: adult onset of severe symptoms.
Gilchrist JM; Coleman RA
Ann Intern Med; 1987 Apr; 106(4):556-8. PubMed ID: 3826955
[TBL] [Abstract][Full Text] [Related]
5. Valproate-induced hyperammonemia - uncovering an underlying inherited metabolic disorder: a case report.
Mehta S; Tayabali S; Lachmann R
J Med Case Rep; 2018 May; 12(1):134. PubMed ID: 29769109
[TBL] [Abstract][Full Text] [Related]
6. Hyperammonemic coma due to parenteral nutrition in a woman with heterozygous ornithine transcarbamylase deficiency.
Felig DM; Brusilow SW; Boyer JL
Gastroenterology; 1995 Jul; 109(1):282-4. PubMed ID: 7797025
[TBL] [Abstract][Full Text] [Related]
7. Valproate-induced lethal hyperammonaemic coma in a carrier of ornithine carbamoyltransferase deficiency.
Tokatli A; Coşkun T; Cataltepe S; Ozalp I
J Inherit Metab Dis; 1991; 14(5):836-7. PubMed ID: 1779634
[No Abstract] [Full Text] [Related]
8. Valproate-induced fatal acute hyperammonaemia-related encephalopathy in late-onset ornithine transcarbamylase deficiency.
Kazmierski D; Sharma N; O'Leary K; Ochieng P
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34035022
[TBL] [Abstract][Full Text] [Related]
9. [Hyperammonaemic coma after valproate therapy as adult onset of ornithine transcarbamylase deficiency].
Padilla Mde L; Miguélez M; Riverola A; Bueno J
Med Clin (Barc); 2002 Feb; 118(5):199. PubMed ID: 11852003
[No Abstract] [Full Text] [Related]
10. Congenital hyperammonemia: symptomatic carrier girl patient and her asymptomatic heterozygous mother for ornithine transcarbamylase (OTC) deficiency: specific enzyme diagnostic and kinetic investigations for the detection of heterozygous genostatus.
László A; Karsai T; Várkonyi A
Acta Paediatr Hung; 1991; 31(3):291-7. PubMed ID: 1742044
[TBL] [Abstract][Full Text] [Related]
11. Ornithine transcarbamylase deficiency unmasked because of gastrointestinal bleeding.
Trivedi M; Zafar S; Spalding MJ; Jonnalagadda S
J Clin Gastroenterol; 2001 Apr; 32(4):340-3. PubMed ID: 11276280
[TBL] [Abstract][Full Text] [Related]
12. Fatal cerebral edema from late-onset ornithine transcarbamylase deficiency in a juvenile male patient receiving valproic acid.
Thakur V; Rupar CA; Ramsay DA; Singh R; Fraser DD
Pediatr Crit Care Med; 2006 May; 7(3):273-6. PubMed ID: 16575347
[TBL] [Abstract][Full Text] [Related]
13. Fatal clinical course of ornithine transcarbamylase deficiency in an adult heterozygous female patient.
Heringlake S; Böker K; Manns M
Digestion; 1997; 58(1):83-6. PubMed ID: 9018015
[TBL] [Abstract][Full Text] [Related]
14. Study of enzyme defect in a case of ornithine transcarbamylase deficiency.
Qureshi IA; Letarte J; Quellet R
Diabete Metab; 1978 Dec; 4(4):239-41. PubMed ID: 729890
[TBL] [Abstract][Full Text] [Related]
15. Ornithine transcarbamylase deficiency in females: an often overlooked cause of treatable encephalopathy.
Pridmore CL; Clarke JT; Blaser S
J Child Neurol; 1995 Sep; 10(5):369-74. PubMed ID: 7499756
[TBL] [Abstract][Full Text] [Related]
16. Anesthesia management protocol for liver transplantation as treatment for ornithine transcarbamylase deficiency.
Baba C; Yukimasa S; Yasuno R; Ichiyanagi H; Ninagawa J; Kasuya S; Kasahara M; Horikawa R; Nagasaka Y; Suzuki Y
Paediatr Anaesth; 2023 Aug; 33(8):620-630. PubMed ID: 37401903
[TBL] [Abstract][Full Text] [Related]
17. Hyperammonemia in ornithine transcarbamylase-deficient recipients following living donor liver transplantation from heterozygous carrier donors.
Rahayatri TH; Uchida H; Sasaki K; Shigeta T; Hirata Y; Kanazawa H; Mali V; Fukuda A; Sakamoto S; Kasahara M
Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27891735
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive characterization of ureagenesis in the spf
Allegri G; Deplazes S; Rimann N; Causton B; Scherer T; Leff JW; Diez-Fernandez C; Klimovskaia A; Fingerhut R; Krijt J; Kožich V; Nuoffer JM; Grisch-Chan HM; Thöny B; Häberle J
J Inherit Metab Dis; 2019 Nov; 42(6):1064-1076. PubMed ID: 30714172
[TBL] [Abstract][Full Text] [Related]
19. Partial ornithine transcarbamylase deficiency associated with recurrent hyperammonemia, lethargy and depressed sensorium.
Oizumi J; Ng WG; Koch R; Shaw KN; Sweetman L; Velazquez A; Donnell GN
Clin Genet; 1984 Jun; 25(6):538-42. PubMed ID: 6733950
[TBL] [Abstract][Full Text] [Related]
20. Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency.
Batshaw ML; Msall M; Beaudet AL; Trojak J
J Pediatr; 1986 Feb; 108(2):236-41. PubMed ID: 3944708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
